These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 766946)

  • 61. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up.
    Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD
    Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
    Saeter G; Talle K; Solheim OP
    Cancer Chemother Pharmacol; 1995; 36(2):172-5. PubMed ID: 7539339
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas.
    Earhart RH; Amato DJ; Chang AY; Borden EC; Shiraki M; Dowd ME; Comis RL; Davis TE; Smith TJ
    Invest New Drugs; 1990 Feb; 8(1):113-9. PubMed ID: 2188926
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
    Vogl SE; Qazi R; Berenzweig M
    Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl-CCNU, vincristine, and procarbazine.
    Avellanosa AM; West CR; Tsukada Y; Higby DJ; Bakshi S; Reese PA; Jennings E
    Cancer; 1979 Sep; 44(3):839-46. PubMed ID: 225004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phase I study of intravenous menogaril administered intermittently.
    Dodion P; Sessa C; Joss R; Crespeigne N; Willems Y; Kitt M; Abrams J; Finet C; Brewer JE; Adams WJ
    J Clin Oncol; 1986 May; 4(5):767-74. PubMed ID: 2939203
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
    Belt RJ; Stephens R
    Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Wagener DJ; Somers R; Santoro A; Verweij J; Woll PJ; Blackledge G; Schütte HJ; Lentz MA; van Glabbeke M
    Eur J Cancer; 1991; 27(12):1604-5. PubMed ID: 1782068
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase II evaluation of AMSA in adult sarcomas.
    Yap BS; Plager C; Benjamin RS; Murphy WK; Legha SS; Bodey GP
    Cancer Treat Rep; 1981; 65(3-4):341-3. PubMed ID: 6263473
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Orr JW; DiSaia PJ
    Cancer Treat Rep; 1986 Feb; 70(2):271-4. PubMed ID: 3948191
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment of advanced digestive cancer with fluorouracil and methyl-CCNU].
    Fleischer I; Wainstein R; Jovtis S; Colombato LO
    Acta Gastroenterol Latinoam; 1978; 8(3):191-3. PubMed ID: 747086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.
    Saiki JH; Baker LH; Rivkin SE; Shahbender S; Fletcher WS; Athens JW; Balcerzak SP; Bonnet JD
    Cancer; 1986 Nov; 58(10):2196-7. PubMed ID: 3756766
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT; Paroly WS; Pugh RP; Hueser J; Jacobs EM; Pajak TF; Bateman JR
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
    Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
    Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
    Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
    Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.
    Denine EP; Harrison SD; Peckham JC
    Cancer Treat Rep; 1977; 61(3):409-17. PubMed ID: 872140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.